In vitro and in vivo studies to prevent hyperacute rejection.
Miyagawa
S
S
Division of Organ Transplantation, Osaka University Medical School, Japan.
Mikata
M
M
Matsuda
H
H
Ikawa
M
M
Okabe
M
M
Nagasawa
S
S
Matsumoto
M
M
Seya
T
T
Shirakura
R
R
D000208:Acute Disease; D000818:Animals; D000910:Antibodies, Heterophile / Q000097:blood*; D015703:Antigens, CD / Q000096:biosynthesis / Q000276:immunology; D018958:CD55 Antigens / Q000096:biosynthesis / Q000276:immunology; D018957:CD59 Antigens / Q000096:biosynthesis / Q000276:immunology; D003167:Complement Activation; D003169:Complement Inactivator Proteins / Q000096:biosynthesis / Q000276:immunology; D003165:Complement System Proteins / Q000502:physiology*; D004285:Dogs; D004730:Endothelium, Vascular / Q000276:immunology / Q000502:physiology; D004912:Erythrocytes / Q000276:immunology; D015870:Gene Expression; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006168:Guinea Pigs; D006801:Humans; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins / Q000096:biosynthesis / Q000276:immunology; D012756:Sheep; D013552:Swine
D000910:Antibodies, Heterophile; D015703:Antigens, CD; C497857:CD46 protein, human; D018958:CD55 Antigens; D018957:CD59 Antigens; D003169:Complement Inactivator Proteins; D051916:Membrane Cofactor Protein; D008562:Membrane Glycoproteins; D003165:Complement System Proteins